Clin Case Rep. 2022 Sep 19;10(9):e6199. doi: 10.1002/ccr3.6199. eCollection 2022 Sep.
Lenalidomide is an IMiD drug which has been associated with a variety of potential immune related complications. We describe the case of a patient with newly diagnosed multiple myeloma along with a history of systemic mastocytosis who developed evidence of an autoimmune enteropathy shortly after initiating lenalidomide based therapy.